Condition
COPD III/IV
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Active Not Recruiting1
Completed1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07362173Phase 4Active Not Recruiting
Actualities in Procedural Sedation: Remimazolam
NCT06785337Phase 2Recruiting
"The Effect of Inhaled Nitroglycerin for COPD Patients
NCT06760325Not ApplicableEnrolling By InvitationPrimary
The Effect of a Tidal Model-Based Approach Applied During Home Visits on Mental Health Parameters and Hospital Admission Frequency in COPD Patients
NCT01123902Phase 2Completed
Effectiveness of a Hand-held Fan for Breathlessness
Showing all 4 trials